Michael Chlenov

596 total citations
21 papers, 263 citations indexed

About

Michael Chlenov is a scholar working on Spectroscopy, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Michael Chlenov has authored 21 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Spectroscopy, 7 papers in Molecular Biology and 6 papers in Organic Chemistry. Recurrent topics in Michael Chlenov's work include Analytical Chemistry and Chromatography (10 papers), Mass Spectrometry Techniques and Applications (5 papers) and Chemical and Physical Properties in Aqueous Solutions (3 papers). Michael Chlenov is often cited by papers focused on Analytical Chemistry and Chromatography (10 papers), Mass Spectrometry Techniques and Applications (5 papers) and Chemical and Physical Properties in Aqueous Solutions (3 papers). Michael Chlenov collaborates with scholars based in United States, Russia and Canada. Michael Chlenov's co-authors include Boris Y. Zaslavsky, A. Zaslavsky, Arnon Chait, Oliver J. McConnell, Victor Kipnis, С. В. Рогожин, Marius Réglier, Larisa M. Miheeva, N. M. Mestechkina and A. Bach and has published in prestigious journals such as Circulation Research, Journal of Chromatography A and Tetrahedron.

In The Last Decade

Michael Chlenov

20 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Chlenov United States 10 103 85 64 47 36 21 263
Keishiro Miyake Japan 10 211 2.0× 121 1.4× 86 1.3× 118 2.5× 48 1.3× 24 359
Naomi I. Nakano Japan 11 117 1.1× 174 2.0× 56 0.9× 25 0.5× 27 0.8× 27 367
Taro Yamashita Japan 11 102 1.0× 195 2.3× 64 1.0× 56 1.2× 26 0.7× 19 493
Timothy Nowak United States 9 149 1.4× 88 1.0× 87 1.4× 85 1.8× 84 2.3× 15 308
Eric Loeser United States 8 104 1.0× 77 0.9× 104 1.6× 55 1.2× 65 1.8× 20 279
Fabrizio Giorgi Italy 15 177 1.7× 184 2.2× 141 2.2× 54 1.1× 67 1.9× 26 487
Masafumi Yoshimoto Japan 11 51 0.5× 101 1.2× 168 2.6× 9 0.2× 11 0.3× 41 329
Ravindra W. Tejwani United States 8 45 0.4× 88 1.0× 24 0.4× 34 0.7× 18 0.5× 11 269
G. Trummlitz Germany 5 79 0.8× 122 1.4× 165 2.6× 33 0.7× 7 0.2× 14 366
Jennifer Tavares Jacon Freitas Brazil 10 47 0.5× 51 0.6× 62 1.0× 18 0.4× 13 0.4× 20 325

Countries citing papers authored by Michael Chlenov

Since Specialization
Citations

This map shows the geographic impact of Michael Chlenov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Chlenov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Chlenov more than expected).

Fields of papers citing papers by Michael Chlenov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Chlenov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Chlenov. The network helps show where Michael Chlenov may publish in the future.

Co-authorship network of co-authors of Michael Chlenov

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Chlenov. A scholar is included among the top collaborators of Michael Chlenov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Chlenov. Michael Chlenov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pu, Jun, Kangwen Deng, John A. Butera, et al.. (2010). De novo synthesis of teleocidin B analogs. Tetrahedron. 66(11). 1963–1972. 5 indexed citations
2.
Shen, Zhongqi, Nicole T. Hatzenbuhler, Deborah A. Evrard, et al.. (2009). Synthesis and structure–activity relationship of novel lactam-fused chroman derivatives having dual affinity at the 5-HT1A receptor and the serotonin transporter. Bioorganic & Medicinal Chemistry Letters. 20(1). 222–227. 14 indexed citations
3.
Chlenov, Michael, et al.. (2009). Normal-Phase Automated Mass-Directed HPLC Purification of a Pyrrolobenzodiazepine Library with Vasopressin Agonist Activity. Journal of Combinatorial Chemistry. 11(4). 704–719. 8 indexed citations
4.
Chlenov, Michael, et al.. (2008). Optimization of normal-phase chromatographic separation of compounds with primary, secondary and tertiary amino groups. Journal of Chromatography A. 1194(1). 80–89. 10 indexed citations
5.
Zhou, Dahui, Nicole T. Hatzenbuhler, Jonathan Groß, et al.. (2007). Novel pyridyl-fused 3-amino chroman derivatives with dual action at serotonin transporter and 5-HT1A receptor. Bioorganic & Medicinal Chemistry Letters. 17(11). 3117–3121. 8 indexed citations
6.
Chlenov, Michael, et al.. (2006). Normal-phase chiral liquid chromatography–mass spectrometry of non-UV-active compounds: Applications for pharmaceutically relevant racemates. Journal of Chromatography A. 1120(1-2). 82–88. 10 indexed citations
7.
Chlenov, Michael, et al.. (2004). Normal-phase high-performance liquid chromatographic separations using ethoxynonafluorobutane as hexane alternative. Journal of Chromatography A. 1033(2). 321–331. 18 indexed citations
8.
Chlenov, Michael, et al.. (2004). Mass‐Directed Normal‐Phase Preparative HPLC with Atmospheric Pressure Chemical Ionization Detection. Journal of Liquid Chromatography & Related Technologies. 27(12). 1817–1834. 8 indexed citations
9.
Zaslavsky, A., Michael Chlenov, Oliver J. McConnell, et al.. (2003). Relative hydrophobicity and lipophilicity of drugs measured by aqueous two-phase partitioning, octanol-buffer partitioning and HPLC. A simple model for predicting blood–brain distribution. European Journal of Medicinal Chemistry. 38(4). 391–396. 57 indexed citations
10.
Elokdah, Hassan, et al.. (2002). Novel human metabolites of the angiotensin-II antagonist tasosartan and their pharmacological effects. Bioorganic & Medicinal Chemistry Letters. 12(15). 1967–1971. 4 indexed citations
11.
Zaslavsky, A., et al.. (2002). Relative hydrophobicity and lipophilicity of β-blockers and related compounds as measured by aqueous two-phase partitioning, octanol–buffer partitioning, and HPLC. European Journal of Pharmaceutical Sciences. 17(1-2). 81–93. 45 indexed citations
12.
Sorota, Steve, et al.. (1998). ATP-Dependent Activation of the Atrial Acetylcholine-Induced K + Channel Does Not Require Nucleoside Diphosphate Kinase Activity. Circulation Research. 82(9). 971–979. 6 indexed citations
13.
Варламов, В. П., Г. Е. Банникова, Michael Chlenov, et al.. (1995). New approaches to chromatographic purification of bovine dopamine-β-hydroxylase. Journal of Chromatography A. 711(1). 113–118. 3 indexed citations
14.
Chlenov, Michael, et al.. (1995). Synthesis of indane derivatives as mechanism-based inhibitors of dopamine β-hydroxylase. Bioorganic & Medicinal Chemistry Letters. 5(9). 941–944. 13 indexed citations
15.
Chlenov, Michael, et al.. (1993). High-performance liquid chromatography of human glycoprotein hormones. Journal of Chromatography A. 631(1-2). 261–267. 12 indexed citations
16.
Рогожин, С. В., et al.. (1988). The partial acidic hydrolysis of chitosan. Polymer Science U.S.S.R.. 30(3). 607–614. 14 indexed citations
18.
Kochetkov, N. K., et al.. (1973). The epimerisation of monosaccharides by γ-irradiation in frozen, aqueous solutions. Carbohydrate Research. 28(1). 86–88. 5 indexed citations
19.
Kochetkov, N. K., et al.. (1964). Formation of desoxysugars in the radiolysis of alpha-methylglucoside. Russian Chemical Bulletin. 13(11). 2021–2021. 2 indexed citations
20.
Sokolov, S. D., et al.. (1963). Structure of 3-methyl-4-nitroisoxazolone-5. Russian Chemical Bulletin. 12(5). 858–859. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026